The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
The GABA system in anxiety and depression and its therapeutic potential
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Neuronal Oscillations in Cortical Networks
Buzsáki, G., & Draguhn, A. (2004) · Science · doi:10.1126/science.1099745 · Cited by 6,576
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations
Klausberger, T., & Somogyi, P. (2008) · Science · doi:10.1126/science.1149381 · Cited by 2,050
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
Phelps, E. A., Delgado, M. R., Nearing, K. I., & LeDoux, J. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.042 · Cited by 1,753
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Amygdala circuitry mediating reversible and bidirectional control of anxiety
Tye, K. M., Prakash, R., Kim, S.-Y., Fenno, L. E., Grosenick, L., Zarabi, H., Thompson, K. R., Gradinaru, V., Ramakrishnan, C., & Deisseroth, K. (2011) · Nature · doi:10.1038/nature09820 · Cited by 1,289 · cited 1×
“This inhibitory tone is reduced through the aversive stimulus; the ensuing disinhibition of the CEA output neurons gates conditioned freezing (Ehrlich et al., 2009; Tye et al., 2011).”
BackgroundLeDoux, J. (2007) · Current Biology · doi:10.1016/j.cub.2007.08.005 · Cited by 1,281
GABA regulates synaptic integration of newly generated neurons in the adult brain
Ge, S., Goh, E. L. K., Sailor, K. A., Kitabatake, Y., Ming, G.-L., & Song, H. (2006) · Nature · doi:10.1038/nature04404 · Cited by 1,264
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Self-citationLi, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · cited 1×
“Furthermore, both CEl and CEm express high levels of neuropeptides which show anxiety and stress-related behavior (Huber et al., 2005; Koob, 2008).”
BackgroundGABAA receptors: Subtypes provide diversity of function and pharmacology
Olsen, R. W., & Sieghart, W. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.045 · Cited by 982
Neurocognitive mechanisms of anxiety: An integrative account
Bishop, S. J. (2007) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2007.05.008 · Cited by 976
Switching on and off fear by distinct neuronal circuits
Herry, C., Ciocchi, S., Senn, V., Demmou, L., Müller, C., & Lüthi, A. (2008) · Nature · doi:10.1038/nature07166 · Cited by 950 · cited 3×
“A shift in the firing activity of fear neurons to extinction neurons is linked to the behavioral shift from fear to no-fear response (Herry et al., 2008, 2010).”
BackgroundMolecular and neuronal substrate for the selective attenuation of anxiety
Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Rülicke, T., Bluethmann, H., Möhler, H., et al. (2000) · Science · doi:10.1126/science.290.5489.131 · Cited by 946
McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944
The GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930
Encoding of conditioned fear in central amygdala inhibitory circuits
Ciocchi, S., Herry, C., Grenier, F., Wolff, S. B. E., Letzkus, J. J., Vlachos, I., Ehrlich, I., Sprengel, R., Deisseroth, K., Stadler, M. B., et al. (2010) · Nature · doi:10.1038/nature09559 · Cited by 924
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Amygdala inhibitory circuits and the control of fear memory
Ehrlich, I., Humeau, Y., Grenier, F., Ciocchi, S., Herry, C., & Lüthi, A. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.026 · Cited by 878
Trait anxiety and impoverished prefrontal control of attention.
Bishop, S. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2242 · Cited by 869
Siegle, G. J., Thompson, W., Carter, C. S., Steinhauer, S. R., & Thase, M. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.048 · Cited by 857
Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846
Genetic dissection of an amygdala microcircuit that gates conditioned fear
Haubensak, W., Kunwar, P. S., Cai, H., Ciocchi, S., Wall, N. R., Ponnusamy, R., Biag, J., Dong, H.-W., Deisseroth, K., Callaway, E. M., et al. (2010) · Nature · doi:10.1038/nature09553 · Cited by 840 · cited 1×
“CEloff neurons are presumably characterized by the expression of PKCd (Habensak et al., 2010).”
BackgroundMalberg, J. E., & Duman, R. S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300234 · Cited by 815
Quirk, G. J., Repa, J. C., & LeDoux, J. E. (1995) · Neuron · doi:10.1016/0896-6273(95)90092-6 · Cited by 808
Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala
Huber, D., Veinante, P., & Stoop, R. (2005) · Science · doi:10.1126/science.1105636 · Cited by 804
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
GABAergic Excitation Promotes Neuronal Differentiation in Adult Hippocampal Progenitor Cells
Tozuka, Y., Fukuda, S., Namba, T., Seki, T., & Hisatsune, T. (2005) · Neuron · doi:10.1016/j.neuron.2005.08.023 · Cited by 742
Serotoninergic regulation of emotional and behavioural control processes
Cools, R., Roberts, A. C., & Robbins, T. W. (2008) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2007.10.011 · Cited by 656 · cited 1×
“Emotionality is strongly influenced by serotonin (Cools et al., 2007) in line with the treatment of anxiety disorders and depressionwith SSRIs.”
BackgroundCollinson, N., Kuenzi, F. M., Jarolimek, W., Maubach, K. A., Cothliff, R., Sur, C., Smith, A., Otu, F. M., Howell, O., Atack, J. R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05572.2002 · Cited by 628 · cited 1×
“Similarly, in mice with an inactivated a5 subunit gene, spatial memory (Morris water maze) was enhanced (Collinson et al., 2002).”
BackgroundSanacora, G., Mason, G. F., Rothman, D. L., Behar, K. L., Hyder, F., Petroff, O. A. C., Berman, R. M., Charney, D. S., & Krystal, J. H. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1043 · Cited by 627 · cited 2×
“A beneficial effect of GABAergic drugs in depression would be expected based on the findings in patients of 1) a deficit in cortical GABA levels (Sanacora et al., 1999, 2000; Hasler et al., 2007) 2) a deficit in cortical GABA-A receptors (Klumpers et al., 2010) and 3) a deficit in the number of…”
BackgroundBaldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Mahan, A. L., & Ressler, K. J. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.06.007 · Cited by 613
5-HT1A receptor function in major depressive disorder
Savitz, J., Lucki, I., & Drevets, W. C. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.009 · Cited by 574
Benzodiazepines: use, abuse, and consequences.
Woods, J. H., Katz, J. L., & Winger, G. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00468-5 · Cited by 560
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., Epperson, C. N., Goddard, A., & Mason, G. F. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001021 · Cited by 553
Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550
Role of GABA in anxiety and depression
Kalueff, A. V., & Nutt, D. J. (2007) · Depression and Anxiety · doi:10.1002/da.20262 · Cited by 534
Neural computations associated with goal-directed choice
Rangel, A., & Hare, T. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.03.001 · Cited by 532
Trace fear conditioning involves hippocampal α 5 GABA A receptors
Crestani, F., Keist, R., Fritschy, J.-M., Benke, D., Vogt, K., Prut, L., Blüthmann, H., Möhler, H., & Rudolph, U. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142288699 · Cited by 528
Self-citationIncreased Cortical GABA Concentrations in Depressed Patients Receiving ECT
Sanacora, G., Mason, G. F., Rothman, D. L., Hyder, F., Ciarcia, J. J., Ostroff, R. B., Berman, R. M., & Krystal, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.577 · Cited by 513
Sanacora, G., Mason, G. F., Rothman, D. L., & Krystal, J. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.663 · Cited by 494
Neuronal circuits of fear extinction
Herry, C., Ferraguti, F., Singewald, N., Letzkus, J. J., Ehrlich, I., & Lüthi, A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07101.x · Cited by 484
Fava, M., McCall, W. V., Krystal, A., Wessel, T., Rubens, R., Caron, J., Amato, D., & Roth, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.016 · Cited by 480
Amygdala intercalated neurons are required for expression of fear extinction
Likhtik, E., Popa, D., Apergis-Schoute, J., Fidacaro, G. A., & Paré, D. (2008) · Nature · doi:10.1038/nature07167 · Cited by 474 · cited 2×
“During extinction, cortical neurons are thought to inhibit the amygdala output presumably through the GABA neurons of the ICM (intercalated cell masses) of the amygdala as a switching circuit that can block LTP (Likhtik et al., 2008) and guide appropriate behavior (Sah”
BackgroundBremner, J. D., Innis, R. B., Southwick, S. M., Staib, L., Zoghbi, S., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1120 · Cited by 453
Two different lateral amygdala cell populations contribute to the initiation and storage of memory
Repa, J. C., Muller, J., Apergis, J., Desrochers, T. M., Zhou, Y., & LeDoux, J. E. (2001) · Nature Neuroscience · doi:10.1038/89512 · Cited by 439
Reversal of pathological pain through specific spinal GABAA receptor subtypes
Knabl, J., Witschi, R., Hösl, K., Reinold, H., Zeilhofer, U. B., Ahmadi, S., Brockhaus, J., Sergejeva, M., Hess, A., Brune, K., et al. (2008) · Nature · doi:10.1038/nature06493 · Cited by 438
Self-citationGABAA Receptor Trafficking-Mediated Plasticity of Inhibitory Synapses
Luscher, B., Fuchs, T., & Kilpatrick, C. L. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.024 · Cited by 434
Rajkowska, G., O'Dwyer, G., Teleki, Z., Stockmeier, C. A., & Miguel-Hidalgo, J. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301234 · Cited by 430
Stuck in a rut: rethinking depression and its treatment
Holtzheimer, P. E., & Mayberg, H. S. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2010.10.004 · Cited by 430
Don't worry ‘B’ happy!: a role for GABAB receptors in anxiety and depression
Cryan, J. F., & Kaupmann, K. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.11.004 · Cited by 421
Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition
Bissière, S., Humeau, Y., & Lüthi, A. (2003) · Nature Neuroscience · doi:10.1038/nn1058 · Cited by 418
Bergami, M., Rimondini, R., Santi, S., Blum, R., Götz, M., & Canossa, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803702105 · Cited by 415
GATA-3 Is Involved in the Development of Serotonergic Neurons in the Caudal Raphe Nuclei
Hikke van Doorninck, J., van der Wees, J., Karis, A., Goedknegt, E., Coesmans, M., Rutteman, M., Grosveld, F., & De Zeeuw, C. I. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-j0002.1999 · Cited by 415
Cognitive Dysfunction in Schizophrenia: Convergence of γ-Aminobutyric Acid and Glutamate Alterations
Lewis, D. A., & Moghaddam, B. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1372 · Cited by 404
Neural bases for addictive properties of benzodiazepines
Tan, K. R., Brown, M., Labouèbe, G., Yvon, C., Creton, C., Fritschy, J.-M., Rudolph, U., & Lüscher, C. (2010) · Nature · doi:10.1038/nature08758 · Cited by 397
GABA and mood disorders: a brief review and hypothesis
Petty, F. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00025-i · Cited by 377
Amorapanth, P., LeDoux, J. E., & Nader, K. (2000) · Nature Neuroscience · doi:10.1038/71145 · Cited by 374
GABA sets the tempo for activity-dependent adult neurogenesis
Ge, S., Pradhan, D. A., Ming, G.-L., & Song, H. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2006.11.001 · Cited by 366
Malizia, A. L., Cunningham, V. J., Bell, C. J., Liddle, P. F., Jones, T., & Nutt, D. J. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.715 · Cited by 361
Serotonergic control of the hippocampus via local inhibitory interneurons.
Freund, T. F., Gulyás, A. I., Acsády, L., Görcs, T., & Tóth, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8501 · Cited by 360
Manji, H. K., Moore, G. J., & Chen, G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00979-3 · Cited by 352
Mombereau, C., Kaupmann, K., Froestl, W., Sansig, G., van der Putten, H., & Cryan, J. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300413 · Cited by 350
Dopamine-mediated modulation of odour-evoked amygdala potentials during pavlovian conditioning
Rosenkranz, J. A., & Grace, A. A. (2002) · Nature · doi:10.1038/417282a · Cited by 348
Hippocampal NMDA receptors and anxiety: At the interface between cognition and emotion
Barkus, C., McHugh, S. B., Sprengel, R., Seeburg, P. H., Rawlins, J. N. P., & Bannerman, D. M. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.014 · Cited by 330
Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects
Rupprecht, R., Rammes, G., Eser, D., Baghai, T. C., Schüle, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H. O., Chaperon, F., et al. (2009) · Science · doi:10.1126/science.1175055 · Cited by 328
A Specialized Subclass of Interneurons Mediates Dopaminergic Facilitation of Amygdala Function
Marowsky, A., Yanagawa, Y., Obata, K., & Vogt, K. E. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.029 · Cited by 328
An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression
Zarate, C. A., Payne, J. L., Quiroz, J., Sporn, J., Denicoff, K. K., Luckenbaugh, D., Charney, D. S., & Manji, H. K. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.171 · Cited by 324
Individual differences in trait rumination and the neural systems supporting cognitive reappraisal
RAY, R. D., OCHSNER, K. N., COOPER, J. C., ROBERTSON, E. R., GABRIELI, J. D. E., & GROSS, J. J. (2005) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/cabn.5.2.156 · Cited by 316 · cited 10×
“In initial clinical trials of GAD over 4 weeks, TPA023 (MK 0777) was effective with a significantly superior HAM-A scale reduction compared to placebo (Fig.”
BackgroundInfluentialInhibition of the Amygdala: Key to Pathological States?
QUIRK, G. J., & GEHLERT, D. R. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07087.x · Cited by 314
Neural mechanisms of cognitive reappraisal of negative self-beliefs in social anxiety disorder.
Goldin, P. R., Manber-Ball, T., Werner, K., Heimberg, R., & Gross, J. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.014 · Cited by 305 · cited 10×
“In initial clinical trials of GAD over 4 weeks, TPA023 (MK 0777) was effective with a significantly superior HAM-A scale reduction compared to placebo (Fig.”
BackgroundInfluentialHippocampal involvement in contextual modulation of fear extinction
Ji, J., & Maren, S. (2007) · Hippocampus · doi:10.1002/hipo.20331 · Cited by 297
Nutt, D. J. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810220033004 · Cited by 272
Enna, S. J. (2007) · The Receptors · doi:10.1007/978-1-59745-465-0_1 · Cited by 266
Paré, D., & Collins, D. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02701.2000 · Cited by 264
The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders
Nemeroff, C. B., MD, & PhD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4169 · Cited by 263
Manzanares, P. A. R., Isoardi, N. A., Carrer, H. F., & Molina, V. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2260-05.2005 · Cited by 261
New, A. S., Fan, J., Murrough, J. W., Liu, X., Liebman, R. E., Guise, K. G., Tang, C. Y., & Charney, D. S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.020 · Cited by 252
Fast synaptic subcortical control of hippocampal circuits
Varga, V., Losonczy, A., Zemelman, B. V., Borhegyi, Z., Nyiri, G., Domonkos, A., Hangya, B., Holderith, N., Magee, J. C., & Freund, T. F. (2009) · Science · doi:10.1126/science.1178307 · Cited by 248
Dias, R., Sheppard, W. F. A., Fradley, R. L., Garrett, E. M., Stanley, J. L., Tye, S. J., Goodacre, S., Lincoln, R. J., Cook, S. M., Conley, R., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1166-05.2005 · Cited by 247
Burghardt, N. S., Sullivan, G. M., McEwen, B. S., Gorman, J. M., & LeDoux, J. E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.029 · Cited by 246
An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition
Dawson, G. R., Maubach, K. A., Collinson, N., Cobain, M., Everitt, B. J., MacLeod, A. M., Choudhury, H. I., McDonald, L. M., Pillai, G., Rycroft, W., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092320 · Cited by 241
A call to action: overcoming anxiety through active coping.
LeDoux, J. E., & Gorman, J. M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1953 · Cited by 238
Jonas, J. M., & Cohon, M. S. (1993) · PubMed · Cited by 236
Neural systems underlying approach and avoidance in anxiety disorders
Robin L., A., & Martin, P. P. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.4/raupperle · Cited by 227 · cited 2×
“An enhanced amygdala activation and a hypoactivation of the orbitofrontal (OFC) and medial prefrontal cortex (mPFC) was frequently reported in patients during processing of negative emotional stimuli, in particular in SAD and PTSD but also in GAD (Aupperle and Paulus, 2010; Elman et al., 2009; Goldin et al., 2009; New…”
Structural and functional brain changes in posttraumatic stress disorder.
Nutt, D., & Malizia, A. L. (2004) · PubMed · Cited by 215
A neural switch for active and passive fear
Gozzi, A., Jain, A., Giovanelli, A., Bertollini, C., Crestan, V., Schwarz, A. J., Tsetsenis, T., Ragozzino, D., Gross, C. T., & Bifone, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.008 · Cited by 209 · cited 2×
“The suppression of a particular type of GABA interneuron (type I neuron) in the lateral part of the CeAwas shown to be sufficient to suppress freezing and engage active responses (Gozzi et al., 2010).”
BackgroundLocalization of Dysfunction in Major Depressive Disorder: Prefrontal Cortex and Amygdala
Murray, E. A., Wise, S. P., & Drevets, W. C. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.041 · Cited by 208
Tyagarajan, S. K., Ghosh, H., Yévenes, G. E., Nikonenko, I., Ebeling, C., Schwerdel, C., Sidler, C., Zeilhofer, H. U., Gerrits, B., Muller, D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011824108 · Cited by 204
Earnheart, J. C., Schweizer, C., Crestani, F., Iwasato, T., Itohara, S., Mohler, H., & Lüscher, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3609-06.2007 · Cited by 203
GABAB receptors: synaptic functions and mechanisms of diversity
Ulrich, D., & Bettler, B. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.04.001 · Cited by 200
Sanacora, G., Kendell, S. F., Levin, Y., Simen, A. A., Fenton, L. R., Coric, V., & Krystal, J. H. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.037 · Cited by 199
Tully, K., Li, Y., Tsvetkov, E., & Bolshakov, V. Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704621104 · Cited by 199
Stutzmann, G. E., & LeDoux, J. E. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-j0005.1999 · Cited by 198
Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond
Licata, S. C., & Rowlett, J. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.001 · Cited by 197
A twin study of generalized anxiety disorder and major depression
Roy, M.-A., Neale, M. C., Pedersen, N. L., Mathé, A. A., & Kendler, K. S. (1995) · Psychological Medicine · doi:10.1017/s0033291700037533 · Cited by 190
Atack, J. R., Wafford, K. A., Tye, S. J., Cook, S. M., Sohal, B., Pike, A., Sur, C., Melillo, D., Bristow, L., Bromidge, F., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089920 · Cited by 188
The complexity of the GABAA receptor shapes unique pharmacological profiles
D’Hulst, C., Atack, J. R., & Kooy, R. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.06.009 · Cited by 178
New, A. S., Fan, J., Murrough, J. W., Liu, X., Liebman, R. E., & Guise, K. G. (2009) · PsycEXTRA Dataset · doi:10.1037/e717692011-018 · Cited by 172
The Pharmacology and Mechanisms of Action of New Generation, Non-Benzodiazepine Hypnotic Agents
Sanger, D. J. (2004) · CNS Drugs · doi:10.2165/00023210-200418001-00004 · Cited by 168
Evidence-based pharmacological treatment of generalized anxiety disorder
Baldwin, D. S., Waldman, S., & Allgulander, C. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001434 · Cited by 168
RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors
Ballard, T. M., Knoflach, F., Prinssen, E. P. M., Borroni, E., Vivian, J. A., Basile, J., Gasser, R., Moreau, J., Wettstein, J. G., Buettelmann, B., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1357-7 · Cited by 167
Elman, I., Lowen, S., Frederick, B. B., Chi, W., Becerra, L., & Pitman, R. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.006 · Cited by 165
Searching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics
Nutt, D. J., & Stahl, S. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106927 · Cited by 163
The psychobiology of anxiolytic drugs
Argyropoulos, S. V., Sandford, J. J., & Nutt, D. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00083-8 · Cited by 163
Chowdhury, N., Quinn, J. J., & Fanselow, M. S. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.5.1396 · Cited by 160
Halasy, K., Miettinen, R. A., Szabat, E., & Freund, T. F. (1992) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1992.tb00861.x · Cited by 159
Molecular regulation of cognitive functions and developmental plasticity: impact of GABAAreceptors
Möhler, H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04454.x · Cited by 159
Self-citationPollack, M., Kinrys, G., Krystal, A., McCall, W. V., Roth, T., Schaefer, K., Rubens, R., Roach, J., Huang, H., & Krishnan, R. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.551 · Cited by 158
Behavioral Neurobiology of Anxiety and Its Treatment
Stein, M. B., & Steckler, T. (2010) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-02912-7 · Cited by 154
Rotaru, D. C., Yoshino, H., Lewis, D. A., Ermentrout, G. B., & Gonzalez-Burgos, G. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1970-10.2011 · Cited by 151
Anxiogenic properties of an inverse agonist selective for α3 subunit‐containing GABAA receptors
Atack, J. R., Hutson, P. H., Collinson, N., Marshall, G. R., Bentley, G., Moyes, C. R., Cook, S. M., Collins, I., Wafford, K. A., McKernan, R. M., et al. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706056 · Cited by 148
McEwen, B. S., & Olié, J. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001648 · Cited by 145
Yee, B. K., Hauser, J., Dolgov, V. V., Keist, R., Möhler, H., Rudolph, U., & Feldon, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03642.x · Cited by 145
Self-citationShen, Q., Lal, R., Luellen, B. A., Earnheart, J. C., Andrews, A. M., & Luscher, B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.024 · Cited by 139
Open-Label Trial of Riluzole in Generalized Anxiety Disorder
Mathew, S. J., Amiel, J. M., Coplan, J. D., Fitterling, H. A., Sackeïm, H. A., & Gorman, J. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.12.2379 · Cited by 134
Selective anxiolysis produced by ocinaplon, a GABA A receptor modulator
LIPPA, A. S., Czobor, P., Stark, J., Beer, B., Kostakis, E., Gravielle, M. C., Bandyopadhyay, S., Russek, S. J., Gibbs, T. T., Farb, D. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502579102 · Cited by 134
Impairment of GABAergic Transmission in Depression: New Insights from Neuroimaging Studies
Sanacora, G., Mason, G. F., & Krystal, J. H. (2000) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v14.i1.20 · Cited by 133
Chambers, M. S., Atack, J. R., Carling, R. W., Collinson, N., Cook, S. M., Dawson, G. R., Ferris, P., Hobbs, S. C., O'Connor, D. V., Marshall, G. R., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040863t · Cited by 127
Spatiotemporal specificity of GABAA receptor-mediated regulation of adult hippocampal neurogenesis
Duveau, V., Laustela, S., Barth, L., Gianolini, F., Vogt, K. E., Keist, R., Chandra, D., Homanics, G. E., Rudolph, U., & Fritschy, J. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07782.x · Cited by 124
Selective, Orally Active γ-Aminobutyric Acid A α5 Receptor Inverse Agonists as Cognition Enhancers
Sternfeld, F., Carling, R. W., Jelley, R. A., Ladduwahetty, T., Merchant, K. J., Moore, K. W., Reeve, A. J., Street, L. J., O'Connor, D. V., Sohal, B., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031076j · Cited by 122
Pollack, M. H., Roy‐Byrne, P., Ameringen, M. V., Snyder, H., Brown, C. E., Ondrasik, J., & Rickels, K. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1109 · Cited by 122
Wnt2 Expression and Signaling Is Increased by Different Classes of Antidepressant Treatments
Okamoto, H., Voleti, B., Banasr, M., Sarhan, M., Đurić, V., Girgenti, M. J., Dileone, R., Newton, S. S., & Duman, R. S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.023 · Cited by 121
Bordi, F., LeDoux, J. E., Clugnet, M.-C., & Pavlides, C. (1993) · Behavioral Neuroscience · doi:10.1037/0735-7044.107.5.757 · Cited by 119
The rise of a new GABA pharmacology
Möhler, H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.020 · Cited by 119
Self-citationGABAergic modulation of learned helplessness
Petty, F., & Sherman, A. D. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90210-0 · Cited by 118
Functional mapping of GABAA receptor subtypes in the amygdala
Marowsky, A., Fritschy, J., & Vogt, K. E. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03574.x · Cited by 118
An anxiogenic benzodiazepine receptor ligand induces learned helplessness
Drugan, R. C., Maier, S. F., Skolnick, P., Paul, S. M., & Crawley, J. N. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90096-2 · Cited by 117
GABAB Receptors and Depression: Current Status
Cryan, J. F., & Slattery, D. A. (2010) · Advances in pharmacology · doi:10.1016/s1054-3589(10)58016-5 · Cited by 111
Nutt, D., Besson, M. J., Wilson, S. J., Dawson, G. R., & Lingford-Hughes, A. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.08.008 · Cited by 111
Roles of glutamate signaling in preclinical and/or mechanistic models of depression
Tokita, K., Yamaji, T., & Hashimoto, K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.016 · Cited by 110
Munro, G., Lopez-Garcia, J. A., Rivera‐Arconada, I., Erichsen, H. K., Nielsen, E. Ø., Larsen, J. S., Ahring, P. K., & Mirza, N. R. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.144568 · Cited by 107
Hasler, G., Nugent, A. C., Carlson, P. J., Carson, R. E., Geraci, M., & Drevets, W. C. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.10.1166 · Cited by 101 · cited 3×
“…reduced benzodiazepine binding, observed in a [11C]-flumazenil PET study, with the strongest decrease in cortical areas in particular in OFC, insula (Malizia et al., 1998) and in dlPFC, with the severity of anxiety symptoms correlating with the deficit in GABAA receptors (Hasler et al., 2008).”
BackgroundEszopiclone for the Treatment of Posttraumatic Stress Disorder and Associated Insomnia
Pollack, M. H., Hoge, E. A., Worthington, J. J., Moshier, S. J., Wechsler, R. S., Brandes, M., & Simon, N. M. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05607gry · Cited by 101
Antidepressant-like properties of α2-containing GABAA receptors
Vollenweider, I., Smith, K. S., Keist, R., & Rudolph, U. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.10.009 · Cited by 96
Klumpers, U. M. H., Veltman, D. J., Drent, M. L., Boellaard, R., Comans, E. F. I., Meynen, G., Lammertsma, A. A., & Hoogendijk, W. J. G. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1292-9 · Cited by 95 · cited 3×
“2) Cortical GABAA receptors and cortical GABA neurons are reduced in major depression (Klumpers et al., 2010; Rajkowska et al., 1999, 2007)”
BackgroundMethodThe GABA B receptor as a target for antidepressant drug action
Ghose, S., Winter, M. K., McCarson, K. E., Tamminga, C. A., & Enna, S. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01004.x · Cited by 94
Durant, C. F., Christmas, D. M., & Nutt, D. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_8 · Cited by 93
Krystal, A. D., D, M. F. M., Rubens, R., Wessel, T. C., Caron, J., Wilson, P. J., Roth, T. G., & McCall, W. V. (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26745 · Cited by 91
Porcher, C., Hatchett, C., Longbottom, R. E., McAinch, K., Sihra, T. S., Moss, S. J., Thomson, A. M., & Jovanovic, J. N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.201582 · Cited by 91
Mirza, N. R., Larsen, J. S., Mathiasen, C., Jacobsen, T. A., Munro, G., Erichsen, H. K., Nielsen, A. N., Troelsen, K. B., NIELSEN, E. O., & Ahring, P. K. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138859 · Cited by 89
D, M. F. M., Asnis, G. M., Shrivastava, R. K., Lydiard, B., Bastani, B., Sheehan, D. V., & Roth, T. G. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05571gry · Cited by 87
Griebel, G., Perrault, G., Simiand, J., Cohen, C., Granger, P., Depoortere, H., Françon, D., Avenet, P., Schoemaker, H., Evanno, Y., et al. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00241.x · Cited by 85
Quinn, J. J., Wied, H. M., Ma, Q. D., Tinsley, M. R., & Fanselow, M. S. (2008) · Hippocampus · doi:10.1002/hipo.20424 · Cited by 85
Martin‐Facklam, M., Schoch, P., Bonetti, E. P., Jenck, F., Martin, J. R., Moreau, J., & Haefely, W. E. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11126-9 · Cited by 85
Research in anxiety disorders: From the bench to the bedside
Garner, M. J., Möhler, H., Stein, D. J., Mueggler, T., & Baldwin, D. S. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.011 · Cited by 83
Self-citationRole of GABAA receptors in cognition
Möhler, H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371328 · Cited by 79
Self-citationAtack, J. R., Maubach, K. A., Wafford, K. A., O'Connor, D. V., Rodrigues, A. D., Evans, D. C., Tattersall, F. D., Chambers, M. S., MacLeod, A. M., Eng, W., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157636 · Cited by 77
Pan, B., Dong, Y., Ito, W., Yanagawa, Y., Shigemoto, R., & Morozov, A. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.029 · Cited by 73
Riluzole Augmentation for Treatment-Resistant Depression
Sanacora, G., Kendell, S. F., Fenton, L. R., Coric, V., & Krystal, J. H. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2132 · Cited by 72
L-type voltage-dependent Ca2+ channels mediate expression of presynaptic LTP in amygdala
Fourcaudot, E., Gambino, F., Casassus, G., Poulain, B., Humeau, Y., & Lüthi, A. (2009) · Nature Neuroscience · doi:10.1038/nn.2378 · Cited by 71
Sah, P., & Westbrook, R. F. (2008) · Nature · doi:10.1038/454589a · Cited by 70
Wu, X., & Ċastrén, E. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.023 · Cited by 67
Ator, N. A., Atack, J. R., Hargreaves, R. J., Burns, H. D., & Dawson, G. R. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158303 · Cited by 66
Ator, N. A. (2005) · CNS Spectrums · doi:10.1017/s1092852900009883 · Cited by 59
Refractory Generalized Anxiety Disorder
Pollack, M. H. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.s.7002.06 · Cited by 56
Savić, M. M., Clayton, T., Furtmüller, R., Gavrilović, I., Samardžić, J., Savic, S. D., Huck, S., Sieghart, W., & Cook, J. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.020 · Cited by 55
Atack, J. R. (2009) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)57004-9 · Cited by 52
The Modulation of Synaptic GABAA Receptors in the Thalamus by Eszopiclone and Zolpidem
Jia, F., Goldstein, P. A., & Harrison, N. L. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146084 · Cited by 52
Jonas, J. M., & Hearron, A. E. J. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606000-00003 · Cited by 48
Treatment of depression and concomitant anxiety
Nutt, D. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00110-3 · Cited by 45
D, M. F. M., Schaefer, K., Huang, H., Wilson, A., Iosifescu, D. V., Mischoulon, D., & Wessel, T. C. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05131gry · Cited by 43
Langen, B., Egerland, U., Bernöster, K., Dost, R., Unverferth, K., & Rundfeldt, C. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084681 · Cited by 38
Czobor, P., Skolnick, P., Beer, B., & Lippa, A. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00109.x · Cited by 29
Fiorelli, R., Rudolph, U., Straub, C. J., Feldon, J., & Yee, B. K. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830dc0c7 · Cited by 28
Physiology and Pharmacology of the GABA System: Focus on GABA Receptors
Möhler, H. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0226-6_1 · Cited by 25
Self-citationHorowski, R., & Dorow, R. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1095-1 · Cited by 25
Quinn, J. J., Wied, H. M., Liu, D., & Fanselow, M. S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06727.x · Cited by 24
Manifesto for a European Anxiety Disorders Research Network
Baldwin, D. S., Allgulander, C., Altamura, A. C., Angst, J., Bandelow, B., den Boer, J. A., Boyer, P., Davies, S., Dell’Osso, B. M., Eriksson, E., et al. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.015 · Cited by 24
Laere, K. V., Bormans, G. M., Bohorquez, S. M. S., de Groot, T., Dupont, P. J., Lepeleire, I. D., Hoon, J. N. J. M. D., Mortelmans, L. A., Hargreaves, R. J., Atack, J. R., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.021 · Cited by 23
A Comparison of the Efficacy and Safety of Alprazolam and Desipramine in Depressed Outpatients
Remick, R. A., Keller, F.-E., Buchanan, R. A., Gibson, R. E., & Fleming, J. A. E. (1988) · The Canadian Journal of Psychiatry · doi:10.1177/070674378803300703 · Cited by 23
Hippocampal adult neurogenesis is enhanced by chronic eszopiclone treatment in rats
Methippara, M. M., Bashir, T., Suntsova, N., Szymusiak, R. S., & McGinty, D. (2010) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2010.00833.x · Cited by 21
Navarro, J. F., Burón, E., & Martín‐López, M. (2004) · Aggressive Behavior · doi:10.1002/ab.20032 · Cited by 16
Eszopiclone and fluoxetine enhance the survival of newborn neurons in the adult rat hippocampus
Su, X., Li, X., Banasr, M., & Duman, R. S. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990629 · Cited by 14
Efficacy and Safety of Zopiclone and Eszopiclone in the Treatment of Primary and Comorbid Insomnia
Najib, J. S. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0226-6_18 · Cited by 9
Cited by
Snyder, H. R., Miyake, A., & Hankin, B. L. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.00328 · Cited by 946
The Effects of Psychological Stress on Depression
Yang, L., Zhao, Y., Wang, Y., Liu, L., Zhang, X., Li, B., & Cui, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x1304150831150507 · Cited by 589
Gephyrin: a master regulator of neuronal function?
Tyagarajan, S. K., & Fritschy, J.-M. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3670 · Cited by 425
A major role for common genetic variation in anxiety disorders
Purves, K. L., Coleman, J. R. I., Meier, S. M., Rayner, C., Davis, K. A. S., Cheesman, R., Bækvad-Hansen, M., Børglum, A. D., Wan Cho, S., Jürgen Deckert, J., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0559-1 · Cited by 425
Yunes, R. A., Poluektova, E. U., Dyachkova, M. S., Klimina, K. M., Kovtun, A. S., Averina, O. V., Orlova, V. S., & Danilenko, V. N. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.10.011 · Cited by 376
Metadata
- Authors
- Möhler, H.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 62
- Issue
- 1
- Pages
- 42-53
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2058355900
- Cited by
- 590
- References
- 186
- FWCI
- 11.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.